D-amino acids

D-amino acids
Product Description

As peptide therapeutics experience explosive growth, the need to address the pharmacokinetic liabilities of canonical L-amino acids grows. D-amino acids are less susceptible to enzymatic degradation and, when placed appropriately in a peptide or protein sequence, can confer additional selectivity and potency.

Read more Show less

Aralez Bio

  • US
  • 2021
    On CPHI since
  • 1
    Certificates
  • 1 - 24
    Employees
Company types
Manufacturer/Innovator
Primary activities
Intermediates Manufacturer
View company profile
Categories
more categories Show less
Specifications
  • Supplied from
    United States
More specifications Fewer specifications

Aralez Bio

  • US
  • 2021
    On CPHI since
  • 1
    Certificates
  • 1 - 24
    Employees
Company types
Manufacturer/Innovator
Primary activities
Intermediates Manufacturer
View company profile

More Products from Aralez Bio (4)

  • Other Amino Acid Sidechains

    Product Other Amino Acid Sidechains

  • Other Aromatic Analogs and Derivatives

    Product Other Aromatic Analogs and Derivatives

    Our enzyme platform creates combinatorial diversity by allowing other aromatic subtrates to act nucleophiles and form other aromatic amino acid analogs.
  • N-methylated amino acid analogs

    Product N-methylated amino acid analogs

    N-methylation (and N-alkylation more broadly) increases steric hindrance around the peptide bond, reducing the peptide’s entropy and increasing affinity and selectivity. This modification also confers protease resistance, and the disruption of hydrogen bonds can improve bioavailability.
    Access to N-me...
  • Quaternary Chiral Center Amino Acids

    Product Quaternary Chiral Center Amino Acids

    Previously hard to access, these compounds with all carbon chiral centers are more stable than tertiary chiral centers. Without using enzymes, these structures are very difficult to make using traditional/conventional chemistry.